Literature DB >> 29479703

O- product transfusion, inventory management, and utilization during shortage: the OPTIMUS study.

Nancy M Dunbar1, Mark H Yazer2.   

Abstract

BACKGROUND: Despite conservation strategies, shortages of O- red blood cells (RBCs) occur. The goal of this study was to determine how utilization of O- RBCs can be reduced using age- and location-based O+ substitution for routine transfusions in O- patients during O- shortages. STUDY DESIGN AND METHODS: Recipient age and ABO and D group were obtained for allogeneic RBC transfusions during the 2016 calendar year from 31 participating centers. ABO and D group of each RBC unit was compared to that of the recipient to determine the number of O- RBC units transfused to all patients, the number of RBC units transfused to O- patients, and the number of O- RBC units transfused to O- patients. O- RBC transfusions to O- patients were further analyzed by patient age and location.
RESULTS: The fraction of all transfused RBCs that were O- at the participating centers ranged from 3.0% to 13.9%. The percentage of O- RBCs transfused to O- patients ranged from 36.6% to 93.7%. Hospitals differed in the frequency of issuing O- RBCs for O- patient transfusions (55.9%-100%). Relative to current issuing practice, overall use of O- RBCs could have been reduced by 44.5% if O+ units had been given to all O- patients at least 50 years old, 9.9% for all O- patients at least 80 years old, or 8.7% for all O- critical care patients at least 50 years old.
CONCLUSION: During O- shortages, O+ switching rules based on the recipient's age and hospital location can be applied for routine transfusions to ensure the availability of O- RBC units for O- females of childbearing age.
© 2018 AABB.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29479703     DOI: 10.1111/trf.14547

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Anti-D immunization rates may exceed 50% in many clinically relevant settings, despite varying widely among patient cohorts.

Authors:  Willy Albert Flegel; Franz Friedrich Wagner; Diarmaid Padraig Ó Donghaile
Journal:  Transfusion       Date:  2020-05       Impact factor: 3.157

2.  Conservation of Rh negative Low Titer O Whole Blood (LTOWB) and the need for a national conversation to define its use in trauma transfusion protocols.

Authors:  Marla Troughton; Pampee P Young
Journal:  Transfusion       Date:  2021-03-29       Impact factor: 3.157

3.  Supplemental findings of the 2017 National Blood Collection and Utilization Survey.

Authors:  Mathew R P Sapiano; Jefferson M Jones; Alexandra A Savinkina; Kathryn A Haass; James J Berger; Sridhar V Basavaraju
Journal:  Transfusion       Date:  2020-03       Impact factor: 3.337

4.  Estimating the risks of prehospital transfusion of D-positive whole blood to trauma patients who are bleeding in England.

Authors:  Rebecca Cardigan; Tom Latham; Anne Weaver; Mark Yazer; Laura Green
Journal:  Vox Sang       Date:  2022-01-12       Impact factor: 2.996

5.  Multifaceted Benefit of Whole Blood Versus Lactated Ringer's Resuscitation After Traumatic Brain Injury and Hemorrhagic Shock in Mice.

Authors:  Benjamin E Zusman; Patrick M Kochanek; Zachary S Bailey; Lai Yee Leung; Vincent A Vagni; David O Okonkwo; Ava M Puccio; Lori A Shutter; Keri L Janesko-Feldman; Janice S Gilsdorf; Deborah A Shear; Ruchira M Jha
Journal:  Neurocrit Care       Date:  2020-09-04       Impact factor: 3.532

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.